USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Neurocrine Biosciences Records $959 Million in Q2 Revenue

The Motley Fool +1 ·

NBIX
NBIX Neurocrine Biosciences Inc
$142.70 -0.41%
View chart & analysis →
  1. 1Neurocrine Biosciences recorded $959 million in revenue for the second quarter of 2026.
  2. 2Neurocrine Biosciences showed a 39% year-over-year revenue increase for the second quarter of 2026.
  3. 3Neurocrine Biosciences reported a net income of approximately $144 million for the second quarter.

So what's the key point?

Neurocrine Biosciences' revenue increased by 39 percent compared to last year. This means the company is earning a lot of money.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Short Seller Reports Released: Edison International, International Game Systems, Mars, Glu The Bear Cave · 6d agoAmazon Winds Down Most of Its Core Nova Models in AI Strategy Overhaul Reuters +5 · Jul 29Tilray pursues business diversification with surge in alcohol sales The Motley Fool +1 · 1h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news